The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome

Eitemau Tebyg

• RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia
  gan: Sanders, Mathijs A., et al.
  Cyhoeddwyd: (2015)
• DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells
  gan: Bera, Rabindranath, et al.
  Cyhoeddwyd: (2020)
• Towards personalized therapy in AML: In vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML
  gan: Bernot, KM, et al.
  Cyhoeddwyd: (2013)
• The Evolving Treatment Landscape of AML
  gan: Sabine Blum, et al.
  Cyhoeddwyd: (2022-03-01)
• MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML
  gan: Sanders, Mathijs A., et al.
  Cyhoeddwyd: (2018)